Preventive counseling on weight loss in patients with bronchial asthma according to population-based study

Author(s):  
Maria I. Kashutina ◽  
Yury V. Zhernov ◽  
Anna V. Kontsevaya

Background: asthma and obesity have a close relationship: obesity is a risk factor for asthma, the link of its pathogenesis, a predictor of heavier flow and the worst control. One of the priorities of non-drug therapy of asthma is the fight against overweight. Preventive counseling allows doctors to teach patients the principles of a healthy lifestyle, including controlling body weight. There is no domestic population-based research reflects the coverage of overweighted persons with asthma of the counseling on weight loss in various socio-demographic groups. Thus our study is actual. Aims: Determine socio-demographic groups among overweighted patients with asthma that doesnt receive a counseling on weight loss. Materials and methods: This study based on cross-section population-based study "Know Your Heart" (2015-2018, Arkhangelsk, Novosibirsk, n=4504). For this research we selected overweighted patients with asthma (n=167). We applied the decision tree to identify socio-demographic groups that havent received a counseling on weight loss. Results: The probability of obtaining a counseling on weight loss increased by 1.39 times among obesity and pension status in women compared with the coverage level of counseling in the studied sample as a whole (61.7%). Among the men, the probability of obtaining a counseling on weight loss increased 1.27 times in the presence of obesity. Reducing the likelihood of getting counseling both among women (1.39 times compared with the general indicator) and among men (2.2 times compared with the general indicator) was noted if their weight corresponded to the category of excess body. Conclusion: 61.7% of the overweighted urban population of Russia with asthma received a counseling on weight loss. Groups of overweighted patients with asthma, which are statistically significantly less often obtaining counseling on weight loss: persons with BMI=25.0-29.9, regardless of gender, and non-retired women with BMI30.0. The decision tree developed by us will allow allergists-immunologists and other doctors to be wary of patients from the population groups identified in the study who are not covered by counseling. In turn, this will increase the coverage of patients from risk groups with counseling and, as a result, will contribute to improving asthma control.

2015 ◽  
Vol 33 (2) ◽  
pp. 99-106 ◽  
Author(s):  
Hyun Kyung Kim ◽  
Ji Young Kim ◽  
Jong Hyen Kim ◽  
Hee Kyoung Hyoung

2021 ◽  
Vol 8 (3) ◽  
Author(s):  
Koichi Miyashita ◽  
Eiji Nakatani ◽  
Hironao Hozumi ◽  
Yoko Sato ◽  
Yoshiki Miyachi ◽  
...  

Abstract Background Seasonal influenza remains a global health problem; however, there are limited data on the specific relative risks for pneumonia and death among outpatients considered to be at high risk for influenza complications. This population-based study aimed to develop prediction models for determining the risk of influenza-related pneumonia and death. Methods We included patients diagnosed with laboratory-confirmed influenza between 2016 and 2017 (main cohort, n = 25 659), those diagnosed between 2015 and 2016 (validation cohort 1, n = 16 727), and those diagnosed between 2017 and 2018 (validation cohort 2, n = 34 219). Prediction scores were developed based on the incidence and independent predictors of pneumonia and death identified using multivariate analyses, and patients were categorized into low-, medium-, and high-risk groups based on total scores. Results In the main cohort, age, gender, and certain comorbidities (dementia, congestive heart failure, diabetes, and others) were independent predictors of pneumonia and death. The 28-day pneumonia incidence was 0.5%, 4.1%, and 10.8% in the low-, medium-, and high-risk groups, respectively (c-index, 0.75); the 28-day mortality was 0.05%, 0.7%, and 3.3% in the low-, medium-, and high-risk groups, respectively (c-index, 0.85). In validation cohort 1, c-indices for the models for pneumonia and death were 0.75 and 0.87, respectively. In validation cohort 2, c-indices for the models were 0.74 and 0.87, respectively. Conclusions We successfully developed and validated simple-to-use risk prediction models, which would promptly provide useful information for treatment decisions in primary care settings.


2017 ◽  
Vol 2 (1) ◽  
pp. 138-138
Author(s):  
Maryam Tayefi ◽  
Habibollah Esmaeily ◽  
Majid Ghayour-Mobarhan ◽  
Ali Reza Amirabadi zadeh

2020 ◽  
Vol 91 (8) ◽  
pp. 867-875 ◽  
Author(s):  
Mark R Janse van Mantgem ◽  
Ruben P A van Eijk ◽  
Hannelore K van der Burgh ◽  
Harold H G Tan ◽  
Henk-Jan Westeneng ◽  
...  

ObjectiveTo determine the prevalence and prognostic value of weight loss (WL) prior to diagnosis in patients with amyotrophic lateral sclerosis (ALS).MethodsWe enrolled patients diagnosed with ALS between 2010 and 2018 in a population-based setting. At diagnosis, detailed information was obtained regarding the patient’s disease characteristics, anthropological changes, ALS-related genotypes and cognitive functioning. Complete survival data were obtained. Cox proportional hazard models were used to assess the association between WL and the risk of death during follow-up.ResultsThe data set comprised 2420 patients of whom 67.5% reported WL at diagnosis. WL occurred in 71.8% of the bulbar-onset and in 64.2% of the spinal-onset patients; the mean loss of body weight was 6.9% (95% CI 6.8 to 6.9) and 5.5% (95% CI 5.5 to 5.6), respectively (p<0.001). WL occurred in 35.1% of the patients without any symptom of dysphagia. WL is a strong independent predictor of survival, with a dose response relationship between the amount of WL and the risk of death: the risk of death during follow-up increased by 23% for every 10% increase in WL relative to body weight (HR 1.23, 95% CI 1.13 to 1.51, p<0.001).ConclusionsThis population-based study shows that two-thirds of the patients with ALS have WL at diagnosis, which also occurs independent of dysphagia, and is related to survival. Our results suggest that WL is a multifactorial process that may differ from patient to patient. Gaining further insight in its underlying factors could prove essential for future therapeutic measures.


Neurology ◽  
2001 ◽  
Vol 56 (5) ◽  
pp. 655-659 ◽  
Author(s):  
M. Vanhanen ◽  
M. Kivipelto ◽  
K. Koivisto ◽  
J. Kuusisto ◽  
L. Mykkanen ◽  
...  

2005 ◽  
Vol 120 (2) ◽  
pp. 157-164 ◽  
Author(s):  
Matthew D. Redelings ◽  
Frank Sorvillo ◽  
Paul Simon

Objectives. Pneumococcal disease is an important cause of vaccine-preventable mortality. It is important to understand the burden and distribution of mortality so that prevention efforts can be targeted appropriately. This study evaluated pneumococcal disease mortality and its demographic correlates in California from 1989 to 1998. Methods. Deaths due to pneumococcal disease were identified from statewide vital records data using multiple cause-coded information. Denominator data were obtained from estimates from the California Department of Finance. Crude and age-adjusted mortality rates and 95% confidence intervals were calculated for each age, gender, and racial/ethnic group. Results. The age-adjusted pneumococcal disease mortality rate was 2.05 deaths per 100,000 population. Mortality was highest in elderly individuals (reaching 38.29 deaths per 100,000 population in individuals older than age 85). Age-adjusted mortality rates were elevated in the African American race/ethnicity group (2.96 deaths per 100,000 population) and males (2.67 deaths per 100,000 population). The majority of individuals who died of pneumococcal disease (78.9%) fell into at-risk groups indicated for vaccination. The majority of all pneumococcal deaths were caused by pneumococcal pneumonia. Mortality was seasonal, reaching a peak in the winter months. A decreasing trend in mortality was observed over the 10-year period examined. Conclusions. Pneumococcal disease remains a significant cause of vaccine-preventable mortality in the California population. Greater efforts must be made to vaccinate at-risk individuals, especially those in demographic groups at highest risk of death.


Author(s):  
Katarzyna Zawisza ◽  
Beata Tobiasz-Adamczyk ◽  
Aleksander Galas ◽  
Katarzyna Jabłońska ◽  
Tomasz Grodzicki

Abstract The study aimed to verify an association between changes in body mass index (BMI) and quality of life (QoL) in a 4-year follow-up in a population-based study in Poland. The results covered data from 1557 adults from the general Polish population who participated in the follow-up survey, performed in two waves: 2011 (COURAGE in Europe); 2015/2016 (COURAGE-POLFUS). Anthropometric measurements and a structured questionnaire including the WHOQOL-AGE scale were used. Regression models were applied to verify whether the observed BMI–QoL association is linear or U-shaped. The inverse U-shaped association between BMI changes and QoL among Polish adults was found using a univariable model. This association was observed in women, whereas in men a linear relationship was found. At the population level, weight loss (BMI decrease of 5–10%) was associated with better QoL in healthy people. The reverse was true in sick people, whose weight loss was observed to be an indicator of poorer QoL. In conclusion, the study suggests an inverse U-shaped association between BMI and quality of life. Better QoL may be considered an additional benefit of public weight loss programs for healthy adults. Further studies focusing on people with some chronic diseases are needed.


2020 ◽  
Vol 159 (1) ◽  
pp. 129-138.e9 ◽  
Author(s):  
Prudence R. Carr ◽  
Korbinian Weigl ◽  
Dominic Edelmann ◽  
Lina Jansen ◽  
Jenny Chang-Claude ◽  
...  

2019 ◽  
Vol 38 ◽  
pp. S118-S119
Author(s):  
I. Kristiansen ◽  
Y.H. Hiorth ◽  
A. Ushakova ◽  
O.-B. Tysnes ◽  
G.W. Alves

Sign in / Sign up

Export Citation Format

Share Document